Michael Messenger
Cited by
Cited by
Global regulation of virulence and the stress response by CsrA in the highly adapted human gastric pathogen Helicobacter pylori
FM Barnard, MF Loughlin, HP Fainberg, MP Messenger, DW Ussery, ...
Molecular microbiology 51 (1), 15-32, 2004
The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review
IA Cree, L Uttley, H Buckley Woods, H Kikuchi, A Reiman, S Harnan, ...
BMC cancer 17 (1), 1-17, 2017
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection
F Collinson, M Hutchinson, RA Craven, DA Cairns, A Zougman, TC Wind, ...
Clinical Cancer Research 19 (18), 5227-5239, 2013
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
SH Sim, MP Messenger, WM Gregory, TC Wind, NS Vasudev, J Cartledge, ...
British journal of cancer 107 (7), 1131-1137, 2012
Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual …
PAJ Crosbie, R Gabe, I Simmonds, M Kennedy, S Rogerson, N Ahmed, ...
BMJ open 10 (9), e037075, 2020
Serum aminoacylase-1 is a novel biomarker with potential prognostic utility for long-term outcome in patients with delayed graft function following renal transplantation
MPW Smith, A Zougman, DA Cairns, M Wilson, T Wind, SL Wood, ...
Kidney international 84 (6), 1214-1225, 2013
A comparison of the analytical performance of five commercially available assays for neutrophil gelatinase-associated lipocalin using urine
RL Kift, MP Messenger, TC Wind, S Hepburn, M Wilson, D Thompson, ...
Annals of clinical biochemistry 50 (3), 236-244, 2013
Evaluating diagnostic strategies for early detection of cancer: the CanTest framework
FM Walter, MJ Thompson, I Wellwood, GA Abel, W Hamilton, M Johnson, ...
Bmc Cancer 19 (1), 1-11, 2019
The future for diagnostic tests of acute kidney injury in critical care: evidence synthesis, care pathway analysis and research prioritisation
PS Hall, ED Mitchell, AF Smith, DA Cairns, M Messenger, M Hutchinson, ...
NIHR Journals Library, 2018
Point-of-care creatinine testing for kidney function measurement prior to contrast-enhanced diagnostic imaging: evaluation of the performance of three systems for clinical utility
B Snaith, MA Harris, B Shinkins, M Jordaan, M Messenger, A Lewington
Clinical Chemistry and Laboratory Medicine (CCLM) 56 (8), 1269-1276, 2018
Measuring carbonic anhydrase IX as a hypoxia biomarker: differences in concentrations in serum and plasma using a commercial enzyme-linked immunosorbent assay due to influences …
TC Wind, MP Messenger, D Thompson, PJ Selby, RE Banks
Annals of clinical biochemistry 48 (2), 112-120, 2011
Human Recombinant B7-H3 Expressed in E. coli Enhances T Lymphocyte Proliferation and IL-10 Secretion in Vitro
GB Zhang, YJ Chen, Q Shi, HB Ma, Y Ge, Q Wang, Z Jiang, Y Xu, ...
Acta biochimica et biophysica Sinica 36 (6), 430-436, 2004
Target Product Profiles for medical tests: a systematic review of current methods
P Cocco, A Ayaz-Shah, MP Messenger, RM West, B Shinkins
BMC medicine 18 (1), 1-12, 2020
European multicentre study validates enhanced liver fibrosis test as biomarker of fibrosis in systemic sclerosis
G Abignano, J Blagojevic, LA Bissell, RB Dumitru, S Eng, Y Allanore, ...
Rheumatology 58 (2), 254-259, 2019
Toward a framework for outcome-based analytical performance specifications: a methodology review of indirect methods for evaluating the impact of measurement uncertainty on …
AF Smith, B Shinkins, PS Hall, CT Hulme, MP Messenger
Clinical chemistry 65 (11), 1363-1374, 2019
RIPOSTE: a framework for improving the design and analysis of laboratory-based research
NGD Masca, EMA Hensor, VR Cornelius, FM Buffa, HM Marriott, JM Eales, ...
Elife 4, e05519, 2015
Regenerative medicine: a snapshot of the current regulatory environment and standards.
MP Messenger, PE Tomlins
Adv. Mater. 23 (12), 2011
Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
M Stevenson, A Metry, M Messenger
Health Technology Assessment (Winchester, England) 25 (39), 1, 2021
Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
M Stevenson, A Metry, M Messenger
Health Technology Assessment (Winchester, England) 25 (21), 1, 2021
Identifying novel biomarkers ready for evaluation in low-prevalence populations for the early detection of lower gastrointestinal cancers: a systematic review and meta-analysis
P Druce, N Calanzani, C Snudden, K Milley, R Boscott, D Behiyat, ...
Advances in therapy 38 (6), 3032-3065, 2021
The system can't perform the operation now. Try again later.
Articles 1–20